Treatment of pancreatic cancer: Challenge of the facts

World Journal of Surgery

Volumn 27, Issue 10, 2003, Pages 1075-1084

  Beger, Hans G ^a,e   Rau, Bettina ^b   Gansauge, Frank ^c   Poch, Bertram ^c   Link, Karl Heinz ^d  

^a UNIVERSITY OF ULM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Illertalklinik ^*  (Germany)

^d Asklepios Paulinen Klinik   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LIVER METASTASIS; METASTASIS; MORTALITY; NERVE PLEXUS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS; QUALITY OF LIFE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

HUMANS; PANCREATIC NEOPLASMS;

EID: 0141888993     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7165-7     Document Type: Review

References (89)

1. Hruban RH, Offerhaus GJA, Kern SE. Familial pancreatic cancer. In Cameron JL, editor, Pancreatic Cancer Hamilton, London, Ontario, BC Decker, Inc., 2001;25-36
2. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284
3. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am. J. Gastroenterol. 1985;80:459
4. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg. 1991;161:120
5. Nagakawa T, Kayahara M, Ohta T, et al. Patterns of neural and plexus extensive invasion of human pancreatic cancer and experimental cancer. Int. J. Pancreatol. 1991;10:113
6. Ishikawa O. Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology. 1996;43:320
7. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of adenocarcinoma of the pancreas. Am. J. Surg. 1993;165:68
8. Yeo C, Abrams R, Grochow L, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann. Surg. 1997;225:621
9. Birk D, Fortnage G, Formentini A, et al. Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatol. Biliary Pancreat. Surg. 1998;23:234
10. Beger HG, Gansauge F, Birk D. Lymph node dissection. In Cameron JL, editor, Pancreatic Cancer Hamilton, London, Ontario, BC Decker, Inc., 2001;123-132
11. Ishikawa O, Ohigashi H, Sasaki Y, et al. Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery 1997;121:244-249
12. Hirai I, Murakami G, Kimura W, et al. Origin of the thoracic duct and pancreaticoduodenal lymphatic pathways to the para-aortic lymph nodes. J. Hepatobiliary. Pancreat. Surg. 2001;8:441-448
13. Tsuchiya R, Takatoshi N, Harada N, et al. Collective review of small carcinomas of the pancreas. Ann. Surg. 1986;203:77-81
14. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur. J. Surg. Oncol. 1991;17:167-172
15. Takahashi T, Ishikara H, Kato H, et al. Intra-pancreatic, extratumoral perineural invasion. Acta Pathol. Jpn. 1992;42:99-103
16. Nakao A, Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996;12:357-361
17. Kayahara M, Nagakawa T, Futagami F, et al. Lymphatic flow and neural plexus invasion associated with carcinoma of the body and tail of the pancreas. Cancer 1996;78:2485
18. Heeckt P, Safi F, Binder T, et al. Free intraperitoneal tumor cells in pancreatic cancer-significance for clinical course and therapy. Chirurgie 1992;78:2485
19. Ando N, Nakao A, Nomoto S, et al. Defection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Pancreas 1997;15:374-378
20. Hosch SB, Knoefel WT, Metz S, et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997;15:154-159
21. Demuere MJ, Doffek KM, Komoiowski RA, et al. Adenocarcinoma of the pancreas. Detection of occult metastases in regional lymph nodes by PCR-based assay. Cancer 1998;83:1328-1334
22. Mühling B, Dehner C, Steiger. Micrometastasis in pancreatic head cancer: use of polymerase chain reaction for precise tumor staging. J. Gastrointest. Surg., in press
23. Juhl H, Stritzel M, Wroblewski A, et al. Immunocytological detection of micrometastatic cells. Int. J. Cancer 1994;57:330-335
24. Inoue S, Nakao A, Kasai Y, et al. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis. Jpn. J. Cancer Res. 1995;86:626-630
25. Soeth E, Röder C, Juhl H, et al. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int. J. Cancer 1996;69:278-282
26. Thorban S, Roder JD, Pantel K, et al. Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am. J. Surg. 1996;172:297-298
27. Kayahara M, Nagakawa T, Konishi I, et al. Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int. J. Pancreatol. 1991;10:105-111
28. Nagakawa T, Kayahara M, Ueno K, et al. A clinicopatholgic study on neural invasion in cancer of the pancreatic head. Cancer 1992;69:930-935
29. Ohigashi H, Ishikawa O, Sasaki Y, et al. K-ras point mutation in the nerve plexus around superior mesenteric artery in resectable adenocarcinoma of the pancreatic head. Arch. Surg. 2000;135:1450-1455
30. Birk D, Fortnage G, Formentini A, et al. Carcinoma of the pancreas arising from the uncinate process. Br. J. Surg. 1998;85:498
31. Gordon TA, Burleyson G, Tielsch JM, et al. The effects of regionalization on cost and outcome for one high-risk general surgical procedure. Ann. Surg. 1995;221:43-49
32. Liebermann MD, Killborn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann. Surg. 1995;222:638-645
33. Gouma DJ, van Geenen RCI, van Gulik THM. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann. Surg. 2000;232:786-794
34. Bramhall SR, Allum WH, Jones AG, et al. Treatments and survival in 13. 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br. J. Surg. 1995;82:111-115
35. Neoptolemos JP, Russel RCG, Bramhale S, et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients. Br. J. Surg. 1997;84:1370
36. Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J. Am. Coll. Surg. 1999;189:46-56
37. Scand J Finnish Surg Society Annual Meeting. (1996) 17-45
38. Birkmeyer JD, Finlayson SRG, Tosteson ANA, et al. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 1999;125:250-256
39. Howard J. Pancreaticoduodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann. Surg. 1968;168:629-640
40. Beger HG, Gansauge F, Ramadani M, et al. Morbidity and mortality after pancreatic head resection-monoinstitutional results of 1200 patients. Ann. Surg. 2003, in press
41. Pedrazzoli S, Di Carlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. Ann. Surg. 1998;228:508-517
42. Yeo CL, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymph-adenectomy for periampullary adenocarcinoma. Ann. Surg. 2002;236: 355-368
43. Pedrazzoli S, Beger HG, Obertop H, et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Dig. Surg. 1999;16:337-345
44. Tsuchiya R, Karada N, Tsunoda T, et al. Long-term survivors after operation on carcinoma of the pancreas. Int. J. Pancreatol. 1988;3:401-406
45. Trede M, Schwall G, Seger HD. Survival after pancreatoduodenectomy. 118consecutive resections without an operative mortality. Ann. Surg. 1990;211:447-458
46. Nagakawa T, Kayahar M, Ohta T, et al. Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int. J. Pancreatol. 1991;10:113-119
47. Takahashi S, Ogata Y, Miyazaki H, et al. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J. Surg. 1995;19:653-660
48. Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br. J. Surg. 1995;82: 1686-1691
49. Yeo CL, Sohn TA, Caeron JL, et al. Periampullary adenocarcinoma: analysis of 4-year survivors. Ann. Surg. 1998;227:821-831
50. Takahashi T, Nizno N, Ishikura H, et al. Predictive factors for long-term survival in patients with pancreatic carcinoma. Hepatogastroenterology. 1997;44:1463-1468
51. Nitecki S, Sarr MG, Thomas VC, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann. Surg. 1995;221:59-66
52. Hanyu F, Imaizumi T. Extended radical surgery for carcinoma of the head of the pancreas - Japanese experience. In Beger HG, Büchler M, Schoenberg MH, editors, Cancer of the Pancreas Ulm (Germany), Universitätsverlag, 1996;389-401
53. Tashiro S, Kochino R, Hiraoka T, et al. Surgical indications and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991;109:481-487
54. Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann. Surg. 1992;215:231-236
55. Allema JH, Renders ME, van Gulik TM, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br. J. Surg. 1994;81:1642-1646
56. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br. J. Surg. 1994;81:1190-1193
57. Nakao A, Harada A, Nonami T, et al. Clinical significance of portal vein invasion by pancreatic head carcinoma. Surgery 1995;117:50-55
58. Roder JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: who benefits from portal vein resection? Am. J. Surg. 1996;171: 170-175
59. Harrison LE, Klimstra DS, Murray FB. Isolated portal vein involvement in pancreatic adenocarcinoma. A Contraindication for resection? Ann. Surg. 1996;224:342-349
60. Evans DB, Pisters PWT, Lee JE, et al. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J. Hepatobil. Pancreat. Surg. 1998;5:242-250
61. Launois B, Franci J, Bardayoglou E, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J. Surg. 1999;17: 122
62. Shibada C, Kobari M, Tsuchiya T, et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J. Surg. 2001;25:1002-1005
63. Kawada M, Kondo S, Okushiba S, et al. (2003) "Re-evaluation on indication of radical pancreatectomy for pancreatic carcinoma-is portal vein infiltration a contraindication?" Langenbecks Arch. Surg., in press
64. Griffin JF, Smallay SR, Jewel W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61
65. Westerdahl J, Andrew-Sandberg A, Ihse I. Recurrence of exocrine pancreatic cancer: local or hepatic? Hepatogastroenterology. 1993;40:384
66. Kayahara M, Nagakwa T, Keno K, et al. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118
67. Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br. J. Surg. 1996;83:625-631
68. Iacono C, Bortolasi L, Facci E. Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreatoduodenectomy? J. Gastrointest. Surg. 1997;1:446-453
69. Gudjonsson B. Survival statistics gone awry. Pancreatic cancer, a case in point. J. Clin. Gastroenterol. 2002;35:180-184
70. Glimelius B. Efficacy endpoints in pancreatic cancer trials: an expert's view CRP. The Remedy Ltd, London
71. Storniolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment programme for patients with gemcitabine. Cancer 1999;85: 1261-1268
72. Klinkenbijl JH, Jeekel J, Sahmoud T. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann. Surg. 1999;230:776-784
73. Nguyten TC, Sohn TA, Cameron JL, et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J. Gastrointest. Surg. 2003;7:1-11
74. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 1985; 120:899-903
75. GITSG. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010
76. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann. Surg. 1997;225:621-636
77. Nukui Y, Picozzi VJ, Traverso LW. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. J. Surg. 2000;179:367-371
78. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358:1576-1585
79. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am. J. Surg. 1994;168:361-364
80. Tahakashi S, Ogata Y, Miyazaki H, et al. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J. Surg. 1995;19:653
81. Beger HG, Gansauge F, Büchler MW, et al. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J. Surg. 1999;23:946-949
82. Zerbi A, Fossati U, Perolini D, et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994;73:2930-2935
83. Foo ML, Gunderson LG, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation + 5 fluorouracil. Int. J. Radiat. Oncol. Biol. Phys. 1993; 26:483-489
84. Hiraoka T. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy. Baillieres Clin. Gastroenterol. 1990;4:985
85. Hosotani R, Kogire M, Arii S, et al. Results of pancreatectomy with radiation therapy for pancreatic cancer. Hepatogastroenterology. 1997; 44:1528-1535
86. Farrell TJ, Barbot DJ, Rosato FE. Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann. Surg. 1997;226:66-69
87. Jessup JM, Steele C, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch. Surg. 1993;128:559
88. Spitz F, Abbruzzose J, Janjan N, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J. Clin. Oncol. 1997;15: 928
89. Snady H, Bruckner H, Coopermann A, et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment in patients with regional pancreatic carcinoma. Cancer 2000; 89:314